Metraipolis › archive › dc_a376a544604d

Phase I dose-escalation study of [¹⁷⁷Lu]Lu-LNC1011, a long-circulating dansyl-modified PSMA theranostics, in metastatic castration-resistant prostate cancer — Europe PMC PMID:41993609

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41993609
DOI
10.7150/thno.128143
License (as archived)
solo-consultazione
Archived
2026-10-17T06:42:55.384Z
SHA-256 of the archived text
7addc75fdde6b586ed9ed822e7598fb0b23fcaa69d33ab5f126bde47d3e3ccc6
Stable URL of this page
https://metraipolis.com/documento/dc_a376a544604d

How to cite

Phase I dose-escalation study of [¹⁷⁷Lu]Lu-LNC1011, a long-circulating dansyl-modified PSMA theranostics, in metastatic castration-resistant prostate cancer — Europe PMC PMID:41993609 — Europe PMC (en), https://europepmc.org/article/MED/41993609 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a376a544604d (Metraipolis archive dc_a376a544604d, sha256 7addc75fdde6b586ed9ed822e7598fb0b23fcaa69d33ab5f126bde47d3e3ccc6)
BibTeX
@misc{dca376a544604d,
  title = {Phase I dose-escalation study of [¹⁷⁷Lu]Lu-LNC1011, a long-circulating dansyl-modified PSMA theranostics, in metastatic castration-resistant prostate cancer — Europe PMC PMID:41993609},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41993609},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a376a544604d; sha256 7addc75fdde6b586ed9ed822e7598fb0b23fcaa69d33ab5f126bde47d3e3ccc6},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41993609. Agents can read the archived copy with the MCP tool read_document.